[Antiarrhythmic effect of blocking agent of beta-adrenergic receptors napriline].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002395:Catecholamines / Q000494:pharmacology; D002415:Cats; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D004357:Drug Synergism; D006329:Heart Conduction System / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D011342:Procainamide / Q000627:therapeutic use*; D011343:Procaine / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D013328:Strophanthins / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D013610:Tachycardia / Q000188:drug therapy*; D014241:Trichloroethylene
D000889:Anti-Arrhythmia Agents; D002395:Catecholamines; D013328:Strophanthins; D013565:Sympatholytics; D014241:Trichloroethylene; D011343:Procaine; D011433:Propranolol; D011342:Procainamide; D007545:Isoproterenol
Antinaritmicheskoe deĭstvie blokatora beta-adrenergicheskikh retseptorov naprilina.